Advertisement

Topics

Companies Related to "Hereditary Angioedema Epidemiology Forecast 2025 Report Updated 10102017" [Most Relevant Company Matches] RSS

11:20 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "Hereditary Angioedema Epidemiology Forecast 2025 Report Updated 10102017" found in our extensive corporate database of over 50,000 company records.

Showing "Hereditary Angioedema Epidemiology Forecast 2025 Report Updated 10102017" Companies 1–25 of 433

Relevant

ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products for physician specialists to enable the support of patients with serious diseases for which there is an unmet medical need, and providing rewarding careers to employees. ViroPharma commercializes Cinryze(TM) (C1 esterase inhibitor [human]) for routine prophylaxis a...


Dyax Corp.

Dyax is a fully integrated biopharmaceutical company focused on discovering, developing and commercializing novel biotherapeutics for unmet medical needs. Dyax utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development. Our lead product, DX-88, has been approved under the brand name...

BioRx

Based in Cincinnati Ohio, BioRx is a national specialty pharmacy dedicated to providing highly customized care for small-prevalence diseases such as Hereditary Angioedema. As one of the nation’s fastest growing providers of biotherapeutics and blood fractions, such as Berinert-P, the company’s clinical staff reaches patients and physicians in all...


EvaluatePharm

EvaluatePharma® – helping you to analyse the past and future performance of the pharmaceutical and biotechnology business sector.EvaluatePharma® provides comprehensive coverage of more than 400 companies and over 11,000 products from early stage R&D through to Marketed and beyond, tracking the past and future performance of the pharma and biotech business sectors.Historic sales (since 1986), c...

Verseon Corporation

Verseon Corporation (www.verseon.com, AIM: VSN) is developing disruptive life-science technology to advance global health. The clinical-stage company is using its proprietary, computational drug discovery platform paired with a comprehensive in-house chemistry and biology workflow to build a growing drug development pipeline. The company is applying its pl...

Lev Pharmaceuticals

We are a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Our product candidates are based on C1-esterase inhibitor (C1-INH), a human plasma protein that mediates inflammation and is potentially applicable as a treatment for a range of medical indications. We initiated a Phase III clinical trial of our lead product...

PHARMING

At Pharming we strive to develop outstanding therapies for a range of medical needs based on our unique science and technology. We specialize in the production of human proteins with healthcare potential, highly pure and in large quantities. Healthcare applications vary from treatment of genetic disorders, to repair of tissue damage during surgery and beyond. Our focusPharming today focuses its re...

Sleep Number Corporation

The leader in sleep innovation, Sleep Number delivers proven, quality sleep through effortless, adjustable comfort and biometric sleep tracking. Sleep Number’s revolutionary 360® smart bed and proprietary SleepIQ® technology platform are proving the connection between sleep and well-being. With one of the most comprehensive databases of biometri...

HealthLeaders-InterStudy

Health Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at state and local levels. Updated quarterly and covering 35 states plus the District of Columbia, each report provides a detailed look at:

Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism pr...

BIOTECH Patent News

BIOTECH Patent News is a monthly printed publication that keeps you updated on the latest events in the world of patented biotechnology. This site provides updates on the latest headlines from BIOTECH Patent News, summaries of recently issued US patents, descriptions of biotechnology available for license, and recent commentary and reviews by biotechology legal professionals. BIOTECH Patent Report...

Caro Research

Caro Research is an independent consulting firm specializing in pharmacoeconomics, epidemiology and technology assessment. Our staff, comprised of investigators in medicine, epidemiology, economics, psychology, biostatistics, informatics, and health care policy emphasizes solid research at the forefront of the field. In addition, we have established an extensive network of both academic and privat...

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. is a pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. The initial focus is on inhibitors of plasma kallikrein, which is an important component of the body’s inflammatory response and which, in excess, can l...

Society for Healthcare Epidemiology of America

The Association for Professionals in Infection Control and Epidemiology (APIC)

Hereditary Neuropathy Foundation

Hereditary Neuropathy Foundation (HNF) is a non-profit 501(c)3 organization whose mission is to increase awareness and accurate diagnosis of Charcot-Marie-Tooth disease (CMT) and related inherited neuropathies, support patients and families with critical information to improve quality of life, and support research that will lead to treatments and cures. HN...

Association for Professionals in Infection Control and Epidemiology (APIC)

Medscape, LLC

Medscape is organized by medical specialty, with each supported specialty having its own customized Web site. Specialty content is evaluated, created, and presented under the guidance of a Medscape program director and a medical professional advisory board.Most specialty sites are organized consistently so you'll know where to find your favorite features as you move from specialty to specialty. Ea...

GTC Biotherapeutics

GTC Biotherapeutics develops, produces, and commercializes therapeutic proteins using transgenic animal technology. ATryn®, recombinant human antithrombin, is the first transgenically produced therapeutic protein approved anywhere in the world, having recently been approved by the European Commission (EMEA) for the prophylactic treatment of deep vein thrombosis in patients with hereditary antith...

Biotech Sage

BioTech Sage Report is newsletter that is published monthly. Our report provides quality investment research and information for uncovering the best ideas in stocks and investment strategies. While our email updates focuses on news events, scientific advancements or biotechnology opportunities. Our goal is to provide valuable information to assist you in your investment strategies. The aim of BioT...

Biomonitoring Info

What: An expert specializing in communications to the general public on the scientific techniques for assessing and interpreting the significance of human exposure to natural and synthetic chemicals is available to provide comment and analysis on the upcoming report on biomonitoring by the Centers for Disease Control and Prevention (CDC). For information o...

Genetics & IVF Institute

Genetics & IVF was the first U.S. center to introduce non-surgical ultrasound guided egg retrieval for IVF Genetics & IVF achieved America's first frozen embryo twin birth Genetics & IVF was the first American center to publicly report pregnancies using ICSI (intracytoplasmic sperm injection) Genetics & IVF was the first to medically test patients for certain mutations which cause hereditary breas...

BioTech Stock Report

Each month the Wong's BioTech Stock Report provides a fresh, intuitive, inside look at the science and business of biotech investing. Our report takes you behind the canned quotes from press releases, beyond the momentum-driven stock analysts, and past the hype of mainstream stock-touters. The BioTech Stock Report gets to the core of what makes biotechnology companies tick: Science and Innovation....

Pharmacy Times and U.S. News & World Report

U.S. News & World Report is a multi-platform publisher of news and analysis, which includes the digital-only U.S. News Weekly magazine, www.usnews.com, and www.rankingsandreviews.com. Focusing on Health, Personal Finance, Education, Travel, Cars, and Public Service/Opinion, U.S. News has earned a reputation as the leading provider of service news an...

Invitae, Inc.

Specializing in genetic diagnostics for hereditary disorders, Invitae’s mission is to make multi-use genetic testing more accessible and affordable than ever before.


More From BioPortfolio on "Hereditary Angioedema Epidemiology Forecast 2025 Report Updated 10102017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks